MELANOMA STAGE III
Clinical trials for MELANOMA STAGE III explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can interferon keep melanoma from coming back after surgery?
Disease control CompletedThis completed phase 2 trial tested whether adding alpha interferon to standard surgery helps prevent skin melanoma from returning. 278 participants with stage I-IV melanoma were assigned to one of six groups, including surgery alone, low or high dose interferon, chemotherapy, or…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Bone drug may supercharge immunotherapy against tough melanoma
Disease control CompletedThis study tested whether adding denosumab (a bone-strengthening drug) to standard immunotherapy (pembrolizumab or nivolumab) could help control advanced melanoma that has spread. Researchers enrolled 25 adults with stage III or IV melanoma who had not received prior immunotherap…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New vaccine combo shows promise for hard-to-treat melanoma
Disease control CompletedThis phase 2 trial tested a combination of an experimental cancer vaccine (BNT111) and an immunotherapy drug (cemiplimab) in 184 adults with advanced melanoma that no longer responded to standard immunotherapy. Participants were randomly assigned to receive the combination or eit…
Matched conditions: MELANOMA STAGE III
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC